Nebivolol Hydrochloride

CAS 152520-56-4 14 current records 1 historicalSmall Molecule

Who holds supplier records for Nebivolol Hydrochloride? 14 organisations hold a current record for Nebivolol Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 11 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (8), China (3), Italy (2) and France (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Nebivolol Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/nebivolol-hydrochloride

Reading the evidence

  • 14 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 11 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (14)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Nebivolol Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Nebivolol Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (11)

Certificates of Suitability on the EDQM register for Nebivolol Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 13 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD. TaizhouCN
CEP 2026-093 - Rev 00
Nebivolol hydrochloride, Process A
Sept 2026Inspected Jan 2024
Hungary
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. TaizhouCN
CEP 2022-140 - Rev 03
Nebivolol hydrochloride, Non-micronised, micronised
Aug 2026Inspected May 2026
Italy
ALKEM LABORATORIES LIMITED MumbaiIN
CEP 2024-481 - Rev 01
Nebivolol hydrochloride
Jul 2026—
MACLEODS PHARMACEUTICALS LIMITED MumbaiIN
CEP 2025-575 - Rev 00
Nebivolol hydrochloride, (1083)
Jun 2026—
HETERO DRUGS LIMITED HyderabadIN
CEP 2021-403 - Rev 02
Nebivolol hydrochloride
Apr 2026—
LUSOCHIMICA S.P.A. Casaletto LodigianoIT
CEP 2023-063 - Rev 02
Nebivolol hydrochloride
Mar 2026Inspected Feb 2026
Italy
TORRENT PHARMACEUTICALS LIMITED AhmedabadIN
CEP 2023-122 - Rev 01
Nebivolol hydrochloride
May 2025—
F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A. Montecchio MaggioreIT
CEP 2024-214 - Rev 00
Nebivolol hydrochloride, Micronised
Apr 2025Inspected Apr 2026
Italy
MSN PHARMACHEM PRIVATE LIMITED Sangareddy DistrictIN
CEP 2022-193 - Rev 02
Nebivolol hydrochloride, Crystalline, micronised and non-micronised
Apr 2025—
JIANGSU WEIQIDA PHARMACEUTICAL CO., LTD. Nantong CityCN
CEP 2022-069 - Rev 00
Nebivolol hydrochloride
Apr 2024—
CADILA PHARMACEUTICALS LIMITED AnkleshwarIN
R0-CEP 2022-095 - Rev 00
Nebivolol hydrochloride
Aug 2022—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (1)

Organisations whose Type II DMFs for Nebivolol Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 1 historical record

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Nebivolol Hydrochloride is a selective beta-1 receptor blocker used in the treatment of hypertension and heart failure. It exhibits vasodilatory properties, which help in the reduction of blood pressure.

Chemical identity

IUPAC name
[(2R)-2-[(2R)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-2-hydroxyethyl]-[(2R)-2-[(2S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-2-hydroxyethyl]azanium chloride
Canonical SMILES
C1CC2=C(C=CC(=C2)F)O[C@H]1[C@@H](C[NH2+]C[C@H]([C@@H]3CCC4=C(O3)C=CC(=C4)F)O)O.[Cl-]
InChIKey
JWEXHQAEWHKGCW-VCVZPGOSSA-N
Synonyms
Bystolic API, bystolic, nebivolol hcl, r-067555, r067555

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
beta-Adrenergic Blocker
Mechanism of action
Adrenergic beta-Antagonists

Therapeutic areas

Cardiovascular DiseasesHypertensionHeart Failure

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Nebivolol Hydrochloride?

14 organisations hold an active US FDA Type II Drug Master File or a CEP for Nebivolol Hydrochloride: Hetero Drugs Limited (India), Alkem Laboratories Limited (India), Cadila Pharmaceuticals Limited (India), FIS FABBRICA ITALIANA SINTETICI SPA (Italy), Macleods Pharmaceuticals Ltd. (India), MSN PHARMACHEM PRIVATE LTD (India), Torrent Pharmaceuticals (India) and Zhejiang Ausun Pharmaceutical Co., Ltd. (China), and 6 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Nebivolol Hydrochloride Drug Master Files are active?

Hetero Drugs Limited (DMF 31081, 25296), Alkem Laboratories Limited (DMF 39313), Cadila Pharmaceuticals Limited (DMF 21152), FIS FABBRICA ITALIANA SINTETICI SPA (DMF 22735), Macleods Pharmaceuticals Ltd. (DMF 29996), MSN PHARMACHEM PRIVATE LTD (DMF 24916), Torrent Pharmaceuticals (DMF 22906) and Zhejiang Ausun Pharmaceutical Co., Ltd. (DMF 29730) and 4 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Nebivolol Hydrochloride records mean?

1 organisation has only inactive Type II DMFs for Nebivolol Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Nebivolol Hydrochloride have a European Certificate of Suitability?

Yes. 11 organisations hold a valid CEP for Nebivolol Hydrochloride on the EDQM register, including ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD. Taizhou (CN), ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Taizhou (CN), ALKEM LABORATORIES LIMITED Mumbai (IN), MACLEODS PHARMACEUTICALS LIMITED Mumbai (IN), HETERO DRUGS LIMITED Hyderabad (IN) and LUSOCHIMICA S.P.A. Casaletto Lodigiano (IT) and 5 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Nebivolol Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Nebivolol Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.